Latest filing published 12 Nov 2009 for 180 DEGREE CAPITAL CORP. /NY/, €7,010.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
G. Morgan Browne: trading record in brief
Filings by G. Morgan Browne span 2 companies, the busiest being OSI Pharmaceuticals Inc and 180 Degree Capital Corp. /NY/. The record holds 39 filings, for trades running from 16 March 2006 to 12 November 2009.
Both buying and selling appear: 8 purchases worth €48k, against 23 sales worth €422k. The net balance comes to €374k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 4 option exercises. So far in 2009, the count stands at 1 purchase and no sales.
Half of the purchases are above €6,406 and half below.
The latest filing, published on 12 November 2009, reports an open-market purchase of €7,010 in 180 Degree Capital Corp. /NY/. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to G. Morgan Browne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,274 shares@ US$4.58Common StockSEC:0001127602-09-022445:0Canonical exit: 10 Feb 2010 (T+90)
- 1,535 shares@ US$7.50Common StockSEC:0001127602-08-005959:0Canonical exit: 13 Nov 2008 (T+90)
- 760 shares@ US$6.71Common StockSEC:0001127602-08-002081:0Canonical exit: 22 Jun 2008 (T+90)
- 5,000 shares@ US$6.75Common StockSEC:0001127602-07-001937:0
- 5,000 shares@ US$3.63Common StockSEC:0001127602-07-001937:1
- 100 shares@ US$37.89Common StockSEC:0001127602-07-001937:2
- 100 shares@ US$37.80Common StockSEC:0001127602-07-001937:3
- 34 shares@ US$37.76Common StockSEC:0001127602-07-001937:4
- 766 shares@ US$37.73Common StockSEC:0001127602-07-001937:5
- 100 shares@ US$37.82Common StockSEC:0001127602-07-001937:6
- 400 shares@ US$37.81Common StockSEC:0001127602-07-001937:7
- 609 shares@ US$37.75Common StockSEC:0001127602-07-001937:8
- 1,391 shares@ US$37.74Common StockSEC:0001127602-07-001937:9
- 500 shares@ US$37.65Common StockSEC:0001127602-07-001937:10
- 500 shares@ US$37.70Common StockSEC:0001127602-07-001937:11
- 100 shares@ US$37.68Common StockSEC:0001127602-07-001937:12
- 600 shares@ US$37.69Common StockSEC:0001127602-07-001937:13
- 300 shares@ US$37.64Common StockSEC:0001127602-07-001937:14
- 100 shares@ US$37.61Common StockSEC:0001127602-07-001937:15
- 100 shares@ US$37.66Common StockSEC:0001127602-07-001937:16
- 1,300 shares@ US$37.67Common StockSEC:0001127602-07-001937:17
- 100 shares@ US$37.58Common StockSEC:0001127602-07-001937:18
- 700 shares@ US$37.56Common StockSEC:0001127602-07-001937:19
- 200 shares@ US$37.57Common StockSEC:0001127602-07-001937:20
- 500 shares@ US$37.54Common StockSEC:0001127602-07-001937:21
25 of 38 declarations
